| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CVRx, Inc. | VP OF GLOBAL CLINICAL RESEARCH | Common Stock | 778 | $14,436 | $18.55 | 16 Oct 2023 | Direct |
| CVRx, Inc. | VP OF GLOBAL CLINICAL RESEARCH | Stock Option (right to buy) | 0 | $5.14 | 16 Oct 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CVRX | CVRx, Inc. | 16 Oct 2023 | 2 | +$184 | 4 | VP OF GLOBAL CLINICAL RESEARCH | 18 Oct 2023, 16:51 |
| CVRX | CVRx, Inc. | 18 Jan 2023 | 1 | $0 | 4 | VP OF GLOBAL CLINICAL RESEARCH | 20 Jan 2023, 18:14 |
| CVRX | CVRx, Inc. | 02 Aug 2022 | 1 | $0 | 4 | VP OF GLOBAL CLINICAL RESEARCH | 04 Aug 2022, 20:25 |
| CVRX | CVRx, Inc. | 18 Jan 2022 | 1 | $0 | 4 | VP of Global Clinical Research | 20 Jan 2022, 17:14 |
| CVRX | CVRx, Inc. | 29 Jun 2021 | 1 | $0 | 4 | VP of Global Clinical Research | 01 Jul 2021, 17:28 |
| CVRX | CVRx, Inc. | 29 Jun 2021 | 0 | $0 | 3 | VP of Global Clinical Research | 29 Jun 2021, 21:05 |